Suppr超能文献

1型人类免疫缺陷病毒利用CCR-3作为辅助受体的能力,由包膜V1/V2序列与CCR-5嗜性的V3环共同作用控制。

The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop.

作者信息

Ross T M, Cullen B R

机构信息

Department of Genetics, Duke University Medical Center, Box 3025, Durham, NC 27710, USA.

出版信息

Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7682-6. doi: 10.1073/pnas.95.13.7682.

Abstract

Although infection by primary HIV type 1 (HIV-1) isolates normally requires the functional interaction of the viral envelope protein with both CD4 and the CCR-5 coreceptor, a subset of such isolates also are able to use the distinct CCR-3 receptor. By analyzing the ability of a series of wild-type and chimeric HIV-1 envelope proteins to mediate CCR-3-dependent infection, we have determined that CCR-3 tropism maps to the V1 and V2 variable region of envelope. Although substitution of the V1/V2 region of a CCR-3 tropic envelope into the context of a CCR-5 tropic envelope is both necessary and sufficient to confer CCR-3 tropism, this same substitution has no phenotypic effect when inserted into a CXCR-4 tropic HIV-1 envelope context. However, this latter chimera acquires both CCR-3 and CCR-5 tropism when a CCR-5 tropic V3 loop sequence also is introduced. These data demonstrate that the V1/2 region of envelope can, like the V3 loop region, encode a particular coreceptor requirement and suggest that a functional envelope:CCR-3 interaction may depend on the cooperative interaction of CCR-3 with both the V1/V2 and the V3 region of envelope.

摘要

虽然原发性1型人类免疫缺陷病毒(HIV-1)毒株的感染通常需要病毒包膜蛋白与CD4和CCR-5共受体进行功能性相互作用,但这类毒株的一个子集也能够利用不同的CCR-3受体。通过分析一系列野生型和嵌合HIV-1包膜蛋白介导依赖CCR-3感染的能力,我们确定CCR-3嗜性定位于包膜的V1和V2可变区。虽然将CCR-3嗜性包膜的V1/V2区替换到CCR-5嗜性包膜的背景中对于赋予CCR-3嗜性而言既是必要的也是充分的,但当插入到CXCR-4嗜性HIV-1包膜背景中时,这种相同的替换没有表型效应。然而,当引入CCR-5嗜性V3环序列时,后一种嵌合体同时获得了CCR-3和CCR-5嗜性。这些数据表明,包膜的V1/2区与V3环区一样,能够编码特定的共受体需求,并提示功能性包膜:CCR-3相互作用可能依赖于CCR-3与包膜的V1/V2和V3区的协同相互作用。

相似文献

引用本文的文献

4
Clinical significance of HIV-1 coreceptor usage.HIV-1 辅助受体使用的临床意义。
J Transl Med. 2011 Jan 27;9 Suppl 1(Suppl 1):S5. doi: 10.1186/1479-5876-9-S1-S5.

本文引用的文献

6
Co-receptors for HIV-1 entry.HIV-1进入的共受体。
Curr Opin Immunol. 1997 Aug;9(4):551-62. doi: 10.1016/s0952-7915(97)80110-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验